Biospecimen Core/Immunologic Monitoring and Cellular Products Laboratory
Biospecimen Core/Immunologic Monitoring and Cellular Products Laboratory
批准号:
9091456
负责人:
Lisa Helene Butterfield
金额:
$40.63万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
未结题
起止时间:
2008-08-26 至
关键词:
AftercareAntibody ResponseAntigensAutologousAutologous Dendritic CellsBiological AssayBiological MarkersBiostatistics CoreBloodBlood BanksBlood VesselsC-reactive proteinCD14 geneCD3 AntigensCD4 Positive T LymphocytesCD8 AntigensCD8B1 geneCTAG1 geneCXCL10 geneCXCL11 geneCXCL3 geneCXCL9 geneCellsClinicalClinical ProtocolsClinical TrialsCommunitiesCyclic GMPDataDendritic Cell VaccineEastern Cooperative Oncology GroupEffector CellEquipment and supply inventoriesFlow CytometryGrowthHLA-DR AntigensHelper-Inducer T-LymphocyteIL2RA geneIL8 geneITGAM geneImmune responseImmunityImmunologic MonitoringInfiltrationInformaticsInterferon Alfa-2bInterferon Type IIInterleukin-1 alphaInterleukin-10Interleukin-17Interleukin-2Interleukin-6LaboratoriesLeukapheresisLinkLymphoidMonophenol MonooxygenaseMyelogenousNK Cell ActivationNatural Killer CellsOutcomePatientsPeptidesPeripheral Blood Mononuclear CellProcessProductionProtocols documentationRegulatory T-LymphocyteResearchSILV geneSamplingSerumSiteSkin CancerSuppressor-Effector T-LymphocytesT cell responseT-LymphocyteTNF geneTestingTimeTissue BankingTissue BanksVaccine AntigenVascular Endothelial Growth Factorschemokinecytokineenzyme linked immunospot assaymelanomamonocyteprogramsresponsetumor
中文摘要
核心B作为MSCP孢子的生物标本核心,以及免疫监测和细胞产物实验室(IMCPL)。实验室支持SPORE社区的血液和组织库,为向黑色素瘤项目组织库(#96-099)提交血液和/或肿瘤的患者提供血液和组织库,以及临床协议特定的银行。对于本次更新中提出的所有项目,Core将执行各种标准化的、sop驱动的免疫监测分析。在项目2中,Core B还将制备自体树突状细胞疫苗。
英文摘要
Core B serves the MSCP SPORE as the Biospecimen Core, as well as the Immunologic Monitoring and Cellular Products Laboratory (IMCPL). The laboratory supports the SPORE community with blood and tissue banking for patients submitting blood and/or tumor to the Melanoma Program tissue bank (#96-099), as well as ciinicai protocol-specific banking. For all of the projects proposed in this renewal, the Core wiil perform a wide variety of standardized, SOP-driven immunological monitoring assays. For Project 2, Core B will also prepare autologous dendritic cell vaccines.
Core B will support each Project as follows: Project 1 (Tarhini/Storkus) Core B will support Project 1 Aims 1a and lb, testing circulating cellular and serum biomarkers from the trial ECOG 1609. Core B will assess host effector and suppressor cellular immune responses. We will perform multicolor flow cytometry to compare PBMC before and after treatment, focusing on circulating suppressor cells (Treg and MDSC) and antigen-specific effector and helper T cells, as well as serum biomarkers. Project 2 (Butterfield/Kirkwood): The Core will support Aim 1 (clinical trial #09-021) with autologous AdVTMM2-transduced dendritic cell vaccine manufacture, characterization and release for therapy. The Core will process all blood, leukapheresis and tumor samples and perform all banking For Aim 2, The Core will perform many standardized immune response assays. Project 3 (Zarour/Ferrone): The Core will support this Project with banking of PBMC and testing for activation and expansion of shared melanoma antigen-specific T cells. Project 4 (Falo/Geskin/Tawbi) Core B will perform the systemic immunologic monitoring proposed in Project 4 for both CTCL and melanoma patients. This will include serum, PBMC and tumor sample banking and testing, including innate and effector cell analysis.
Together, the Biospecimen Core B will support the projects of the SPORE with tissue banking (all Projects), standardized immunologic monitoring (all Projects) and cGMP cellular product production for therapy (Project 2). Data generated in Core B will be analyzed in Biostatistics Core C and correlated to clinical parameters. The blood and tissue bank data and inventory are linked to the Clinical Trials Management Application and and will be part of the Research Data Warehouse developed by and managed in Informatics Core D.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMMUNOLOGICAL MONITORING AND CELLULAR PRODUCTS LABORATORY
-
批准号:8181024
-
项目类别:
-
资助金额:$31.05万
-
财政年份:2010
-
负责人:Lisa Helene Butterfield
-
依托单位:
Multiple Tumor Antigen-loaded DC Vaccine for Hepatocellular Cancer
-
批准号:8676457
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2010
-
负责人:Lisa Helene Butterfield
-
依托单位:
Multiple Tumor Antigen-loaded DC Vaccine for Hepatocellular Cancer
-
批准号:8468580
-
项目类别:
-
资助金额:$46.48万
-
财政年份:2010
-
负责人:Lisa Helene Butterfield
-
依托单位:
Multiple Tumor Antigen-loaded DC Vaccine for Hepatocellular Cancer
-
批准号:7780252
-
项目类别:
-
资助金额:$26.74万
-
财政年份:2010
-
负责人:Lisa Helene Butterfield
-
依托单位:
Multiple Tumor Antigen-loaded DC Vaccine for Hepatocellular Cancer
-
批准号:8256634
-
项目类别:
-
资助金额:$40.77万
-
财政年份:2010
-
负责人:Lisa Helene Butterfield
-
依托单位:
Multiple Tumor Antigen-loaded DC Vaccine for Hepatocellular Cancer
-
批准号:8101302
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2010
-
负责人:Lisa Helene Butterfield
-
依托单位:
Multiple Antigen-Engineered DC Immunization and IFNalpha-2b Boost for Metastatic Melanoma
-
批准号:9091452
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2008
-
负责人:Lisa Helene Butterfield
-
依托单位:
Biospecimen Core/Immunologic Monitoring and Cellular Products Laboratory
-
批准号:8933151
-
项目类别:
-
资助金额:$45.82万
-
财政年份:2008
-
负责人:Lisa Helene Butterfield
-
依托单位:
Multiple Antigen-Engineered DC Immunization and IFNalpha-2b Boost for Metastatic
-
批准号:8554630
-
项目类别:
-
资助金额:$22.87万
-
财政年份:2008
-
负责人:Lisa Helene Butterfield
-
依托单位:
Multiple Antigen-Engineered DC Immunization and IFNalpha-2b Boost for Metastatic Melanoma
-
批准号:8933218
-
项目类别:
-
资助金额:$20.14万
-
财政年份:2008
-
负责人:Lisa Helene Butterfield
-
依托单位:
Biospecimen Core/Immunologic Monitoring and Cellular Products Laboratory
-
批准号:8554641
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2008
-
负责人:Lisa Helene Butterfield
-
依托单位:
Multiple Antigen-Engineered DC Immunization and IFNalpha-2b Boost for Metastatic Melanoma
-
批准号:9323325
-
项目类别:
-
资助金额:$21.77万
-
财政年份:2008
-
负责人:Lisa Helene Butterfield
-
依托单位:
Biospecimen Core/Immunologic Monitoring and Cellular Products Laboratory
-
批准号:9323329
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2008
-
负责人:Lisa Helene Butterfield
-
依托单位:
Multiple Antigen-Engineered DC Immunication & IFNa Boost for Metastatic Melanoma
-
批准号:7408306
-
项目类别:
-
资助金额:$13.36万
-
财政年份:2007
-
负责人:Lisa Helene Butterfield
-
依托单位:
AFP-BASED PRIME-BOOST IMMUNOTHERAPY OF HCC
-
批准号:6928669
-
项目类别:
-
资助金额:$30.3万
-
财政年份:2004
-
负责人:Lisa Helene Butterfield
-
依托单位:
AFP-BASED PRIME-BOOST IMMUNOTHERAPY OF HCC
-
批准号:7121963
-
项目类别:
-
资助金额:$29.03万
-
财政年份:2004
-
负责人:Lisa Helene Butterfield
-
依托单位:
AFP-BASED PRIME-BOOST IMMUNOTHERAPY OF HCC
-
批准号:6710922
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2004
-
负责人:Lisa Helene Butterfield
-
依托单位:
IMMUNOLOGICAL MONITORING AND CELLULAR PRODUCTS LABORATORY
-
批准号:8382684
-
项目类别:
-
资助金额:$37.85万
-
财政年份:--
-
负责人:Lisa Helene Butterfield
-
依托单位:
Multiple Antigen-Engineered DC Immunication & IFNa Boost for Metastatic Melanoma
-
批准号:8129531
-
项目类别:
-
资助金额:$17.67万
-
财政年份:--
-
负责人:Lisa Helene Butterfield
-
依托单位:
Multiple Antigen-Engineered DC Immunication & IFNa Boost for Metastatic Melanoma
-
批准号:8379327
-
项目类别:
-
资助金额:$20.4万
-
财政年份:--
-
负责人:Lisa Helene Butterfield
-
依托单位:
海外基金